Literature DB >> 11427571

O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies.

R Pantophlet1, A Nemec, L Brade, H Brade, L Dijkshoorn.   

Abstract

O-antigen-specific monoclonal antibodies (MAbs) are currently being generated to develop an O-serotyping scheme for the genus Acinetobacter and to provide potent tools to study the diversity of O-antigens among Acinetobacter strains. In this report, Acinetobacter baumannii strains from the Czech Republic and from two clonal groups identified in Northwestern Europe (termed clones I and II) were investigated for their reactivity with a panel of O-antigen-specific MAbs generated against Acinetobacter strains from various species. The bacteria were characterized for their ribotype, biotype, and antibiotic susceptibility and the presence of the 8.7-kb plasmid pAN1. By using the combination of these typing profiles, the Czech strains could be classified into four previously defined groups (A. Nemec, L. Janda, O. Melter, and L. Dijkshoorn, J. Med. Microbiol. 48:287-296, 1999): two relatively homogeneous groups of multiresistant strains (termed groups A and B), a heterogeneous group of other multiresistant strains, and a group of susceptible strains. O-antigen reactivity was observed primarily with MAbs generated against Acinetobacter calcoaceticus and Acinetobacter baumannii strains. A comparison of reaction patterns confirmed the previously hypothesized clonal relationship between group A and clone I strains, which are also similar in other properties. The results show that there is limited O-antigen variability among strains with similar geno- and phenotypic characteristics and are suggestive of a high prevalence of certain A. baumannii serotypes in the clinical environment. It is also shown that O-antigen-specific MAbs are useful for the follow-up of strains causing outbreaks in hospitals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427571      PMCID: PMC88187          DOI: 10.1128/JCM.39.7.2576-2580.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  THE HUMAN SKIN AS A SOURCE OF MIMA-HERELLEA INFECTIONS.

Authors:  D TAPLIN; N ZAIAS
Journal:  JAMA       Date:  1963-12-07       Impact factor: 56.272

4.  Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel.

Authors:  K J Towner
Journal:  J Med Microbiol       Date:  1997-09       Impact factor: 2.472

5.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Delineation of new proteolytic genomic species in the genus Acinetobacter.

Authors:  P J Bouvet; S Jeanjean
Journal:  Res Microbiol       Date:  1989 May-Jun       Impact factor: 3.992

7.  Clinical strains of Acinetobacter classified by DNA-DNA hybridization.

Authors:  I Tjernberg; J Ursing
Journal:  APMIS       Date:  1989-07       Impact factor: 3.205

8.  [Clinical importance of Acinetobacter calcoaceticus isolations from blood and venous catheters].

Authors:  M Hoppe; J Potel; R Malottke
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-11

9.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

10.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

View more
  5 in total

1.  Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.

Authors:  Nicole R Luke; Shauna L Sauberan; Thomas A Russo; Janet M Beanan; Ruth Olson; Thomas W Loehfelm; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

2.  Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.

Authors:  Ralph Pantophlet; Juliëtte A Severin; Alexandr Nemec; Lore Brade; Lenie Dijkshoorn; Helmut Brade
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  Identification and characterization of an Acinetobacter baumannii biofilm-associated protein.

Authors:  Thomas W Loehfelm; Nicole R Luke; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

4.  iCN718, an Updated and Improved Genome-Scale Metabolic Network Reconstruction of Acinetobacter baumannii AYE.

Authors:  Charles J Norsigian; Erol Kavvas; Yara Seif; Bernhard O Palsson; Jonathan M Monk
Journal:  Front Genet       Date:  2018-04-10       Impact factor: 4.599

5.  Evaluation of an improved rapid bacterial assay with untreated and pathogen-reduced platelets: Detection of Acinetobacter strains.

Authors:  David LaVerda; Lisa Shinefeld; Nancy Best; Johny Lisitu; Gary Tambolleo; Yli Remo Vallejo
Journal:  Transfusion       Date:  2021-05-27       Impact factor: 3.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.